Literature DB >> 1548287

Antitumor activity of ionic niobocene and molybdenocene complexes in high oxidation states.

P Köpf-Maier1, T Klapötke.   

Abstract

Four air-stable niobocene complexes [(C5H5)2NbCl2]+X- with X = BF4, AsF6, SbF6, SO3CF3 and the molybdenocene derivative [(C5H5)2MoCl2]2+[SbF6]2- were investigated for antitumor properties against Ehrlich ascites tumor in female CF1 mice. All compounds are new, salt-like complexes containing a cationic metallocene moiety, where the early transition metals niobium and molybdenum in the high oxidation states +5 and +6 function as central atoms. The niobocene complexes containing tetrafluoroborate (BF4-) or trifluoromethanesulfonate (CF3SO3-) as anions only induced a maximal cure rate of 50% and led to increases in life span of 182% and 178% following application of optimal doses. The other two niobocene compounds with hexafluoroarsenate (AsF6-) and hexafluoroantimonate (SbF6-) as anions and the molybdenocene derivative [(C5H5)2MoCl2]2+[SbF6]2- effected a maximal cure rate of 100% and increases in life span of 346%, 376%, and 332%, respectively, determined on the key date, i.e., on day 90 after transplantation. On applying the niobocene hexafluoroantimonate complex [(C5H5)2NbCl2] +[SbF6]-, the optimal dose range with a cure rate of 100% was rather broad and extended from 20 mg/kg to 40 mg/kg. Correspondingly, the value of the therapeutic index (TI) was high and amounted to 7.2. In the case of the niobocene hexafluoroarsenate and the molybdenocene hexafluoroantimonate complexes, the TI value decreased to 5.3 and 2.6 respectively. Neither impairments of the general condition nor any conspicuous symptoms could be detected after application of therapeutic doses of the five compounds investigated. Compared to the neutral niobocene dichloro complex [(C5H5)2NbCl2], the therapeutic range of the ionic niobocene derivative [(C5H5)2NbCl2]+[SbF6]- was broadened, the TI value markedly elevated from 2.9 to 7.2, and the toxic symptoms were impressively reduced. The niobocene hexafluoroantimonate complex was the most effective compound investigated in the present study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548287     DOI: 10.1007/bf01410137

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  5 in total

1.  [Molybdocene dichloride as an antitumor agent (author's transl)].

Authors:  P Köpf-Maier; M Leitner; R Voigtländer; H Köpf
Journal:  Z Naturforsch C Biosci       Date:  1979-12

2.  Tumor inhibition by metallocenes: antitumor activity of titanocene dihalides (C5H5)2TiX2 (X=F, Cl, Br, I, NCS) and their application in buffered solutions as a method for suppressing drug-induced side effects.

Authors:  P Köpf-Maier; B Hesse; R Voigtländer; H Köpf
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

3.  Ionic titanocene complexes: a new type of antitumor agent.

Authors:  P Köpf-Maier; E Neuse; T Klapötke; H Köpf
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Antitumor activity of an ionic titanocene tetrachloroferrate derivative against some solid experimental tumors.

Authors:  P Köpf-Maier; T Klapötke
Journal:  Arzneimittelforschung       Date:  1989-04

5.  Ferricenium complexes: a new type of water-soluble antitumor agent.

Authors:  P Köpf-Maier; H Köpf; E W Neuse
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

  5 in total
  4 in total

1.  Bioorganometallic Chemistry of Molybdenocene Dichloride and Its Derivatives.

Authors:  Enrique Meléndez
Journal:  J Organomet Chem       Date:  2012-02-06       Impact factor: 2.369

2.  Niobium uptake and release by bacterial ferric ion binding protein.

Authors:  Yanbo Shi; Ian Harvey; Dominic Campopiano; Peter J Sadler
Journal:  Bioinorg Chem Appl       Date:  2010-04-28       Impact factor: 7.778

3.  Water-soluble molybdenocene complexes with both proliferative and antiproliferative effects on cancer cell lines and their binding interactions with human serum albumin.

Authors:  Idainés Feliciano; Jaime Matta; Enrique Meléndez
Journal:  J Biol Inorg Chem       Date:  2009-06-18       Impact factor: 3.358

Review 4.  Complexes of metals other than platinum as antitumour agents.

Authors:  P Köpf-Maier
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.